Works matching DE "MYXOMA virus"

Results: 28

Myxoma Virus Protein M029 Is a Dual Function Immunomodulator that Inhibits PKR and Also Conscripts RHA/DHX9 to Promote Expanded Host Tropism and Viral Replication.

Published in:

PLoS Pathogens, 2013, v. 9, n. 7, p. 1, doi. 10.1371/journal.ppat.1003465

By:

Rahman, Masmudur M.;
Liu, Jia;
Chan, Winnie M.;
Rothenburg, Stefan;
McFadden, Grant

Publication type:

Article

Evolutionary History and Attenuation of Myxoma Virus on Two Continents.

Published in:

PLoS Pathogens, 2012, v. 8, n. 10, p. 1, doi. 10.1371/journal.ppat.1002950

By:

Kerr, Peter J.;
Ghedin, Elodie;
DePasse, Jay V.;
Fitch, Adam;
Cattadori, Isabella M.;
Hudson, Peter J.;
Tscharke, David C.;
Read, Andrew F.;
Holmes, Edward C.

Publication type:

Article

The α2,3-Sialyltransferase Encoded by Myxoma Virus Is a Virulence Factor that Contributes to Immunosuppression.

Published in:

PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118806

By:

Boutard, Bérengère;
Vankerckhove, Sophie;
Markine-Goriaynoff, Nicolas;
Sarlet, Mickaël;
Desmecht, Daniel;
McFadden, Grant;
Vanderplasschen, Alain;
Gillet, Laurent

Publication type:

Article

Myxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity.

Published in:

PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109801

By:

Tosic, Vesna;
Thomas, Diana L.;
Kranz, David M.;
Liu, Jia;
McFadden, Grant;
Shisler, Joanna L.;
MacNeill, Amy L.;
Roy, Edward J.

Publication type:

Article

Myxoma Virus Oncolytic Efficiency Can Be Enhanced Through Chemical or Genetic Disruption of the Actin Cytoskeleton.

Published in:

PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0084134

By:

Irwin, Chad R.;
Favis, Nicole A.;
Agopsowicz, Kate C.;
Hitt, Mary M.;
Evans, David H.

Publication type:

Article

Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo.

Published in:

PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066825

By:

Ogbomo, Henry;
Zemp, Franz J.;
Lun, Xueqing;
Zhang, Jiqing;
Stack, Danuta;
Rahman, Masmudur M.;
Mcfadden, Grant;
Mody, Christopher H.;
Forsyth, Peter A.

Publication type:

Article

Resistance to Oncolytic Myxoma Virus Therapy in Nf1−/−/Trp53−/− Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon.

Published in:

PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0065801

By:

Zemp, Franz J.;
McKenzie, Brienne A.;
Lun, Xueqing;
Maxwell, Lori;
Reilly, Karlyne M.;
McFadden, Grant;
Yong, V. Wee;
Forsyth, Peter A.

Publication type:

Article

Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells.

Published in:

PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043298

By:

Bartee, Eric;
Meacham, Amy;
Wise, Elizabeth;
Cogle, Christopher R.;
McFadden, Grant;
Kobinger, Gary P.

Publication type:

Article

SEROPREVALENCE AGAINST MYXOMA VIRUS IN LEPUS EUROPAEUS FROM BULGARIA.

Published in:

Tradition & Modernity in Veterinary Medicine, 2024, v. 9, n. 1, p. 3

By:

Manev, Iliyan;
Genova, Krasimira

Publication type:

Article

Apoptosis-inducing effect of myxoma virus on human neuroglioma cell lines.

Published in:

Experimental & Therapeutic Medicine, 2017, v. 14, n. 1, p. 344, doi. 10.3892/etm.2017.4487

By:

QIU-SHENG ZHANG;
MENG ZHANG;
XIAN-JIAN HUANG;
XIAO-JIA LIU;
WEI-PING LI

Publication type:

Article

Recurrent Left Atrial Myxoma in a Young Patient: A Rare Entity.

Published in:

2016

By:

KOTHARI, JIGNESH;
LAKHIA, KETAV;
SOLANKI, PARTH;
PANCHAL, JIGAR;
SHAH, PRATIK

Publication type:

Case Study

Detection of rabbit Haemorrhagic disease virus 2 during the wild rabbit (Oryctolagus cuniculus) eradication from the Berlengas archipelago, Portugal.

Published in:

BMC Veterinary Research, 2017, v. 13, p. 1, doi. 10.1186/s12917-017-1257-3

By:

dos Santos, F. A. Abade;
Carvalho, C.;
Nuno, Oliveira;
Correia, J. J.;
Henriques, M.;
Peleteiro, M. C.;
Fevereiro, M.;
Duarte, M. D.

Publication type:

Article

Genetic characterization of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs.

Published in:

Innate Immunity, 2015, v. 21, n. 8, p. 787, doi. 10.1177/1753425915606209

By:

Neves, Fabiana;
Abrantes, Joana;
Almeida, Tereza;
de Matos, Ana Lemos;
Costa, Paulo P.;
Esteves, Pedro J.

Publication type:

Article

Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor--resistant multiple myeloma.

Published in:

Oncolytic Virotherapy, 2015, v. 4, p. 1, doi. 10.2147/OV.S72372

By:

Dunlap, Katherine M.;
Bartee, Mee Y.;
Bartee, Eric

Publication type:

Article

Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma.

Published in:

Oncolytic Virotherapy, 2013, v. 2, p. 1, doi. 10.2147/OV.S37971

By:

Doty, Rosalinda A.;
Jia Liu;
McFadden, Grant;
Roy, Edward J.;
MacNeill, Amy L.

Publication type:

Article

Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma.

Published in:

Viruses (1999-4915), 2018, v. 10, n. 8, p. 398, doi. 10.3390/v10080398

By:

MacNeill, Amy L.;
Weishaar, Kristen M.;
Séguin, Bernard;
Powers, Barbara E.

Publication type:

Article

Myxoma Virus dsRNA Binding Protein M029 Inhibits the Type I IFN-Induced Antiviral State in a Highly Species-Specific Fashion.

Published in:

Viruses (1999-4915), 2017, v. 9, n. 2, p. 27, doi. 10.3390/v9020027

By:

Rahman, Masmudur M.;
McFadden, Grant

Publication type:

Article

Myxoma Virus and the Leporipoxviruses: An Evolutionary Paradigm.

Published in:

Viruses (1999-4915), 2015, v. 7, n. 3, p. 1020, doi. 10.3390/v7031020

By:

Kerr, Peter J.;
Liu, June;
Cattadori, Isabella;
Ghedin, Elodie;
Read, Andrew F.;
Holmes, Edward C.

Publication type:

Article

Molecular species identification, host preference and detection of myxoma virus in the Anopheles maculipennis complex (Diptera: Culicidae) in southern England, UK.

Published in:

Parasites & Vectors, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13071-015-1034-8

By:

Brugman, Victor A.;
Hernández-Triana, Luis M.;
Prosser, Sean W. J.;
Weland, Chris;
Westcott, David G.;
Fooks, Anthony R.;
Johnson, Nicholas

Publication type:

Article

Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.

Published in:

Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-82

By:

Mingzhe Weng;
Gong Wei;
Mingzhe Ma;
Bingfeng Chu;
Yiyu Qin;
Mingdi Zhang;
Xueqing Lun;
McFadden, Grant;
Forsyth, Peter;
Yong Yang;
Zhiwei Quan

Publication type:

Article

Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia.

Published in:

PLoS Pathogens, 2017, v. 13, n. 3, p. 1, doi. 10.1371/journal.ppat.1006252

By:

Eden, John-Sebastian;
Holmes, Edward C.;
Kerr, Peter J.;
Liu, June;
Cattadori, Isabella M.;
Sim, Derek G.;
Read, Andrew F.;
Rogers, Matthew B.;
Fitch, Adam;
Geber, Adam;
Ghedin, Elodie;
Boag, Brian

Publication type:

Article

Uncommon superficial angiomyxoma of the vulva complicated with condyloma acuminatum and Staphylococcus hominis infection: a mere example of gynecological immunocompromised district.

Published in:

International Journal of Dermatology, 2015, v. 54, n. 11, p. e505, doi. 10.1111/ijd.12931

By:

Caccavale, Stefano;
La Montagna, Maddalena

Publication type:

Article

A bioactive peptide analogue for myxoma virus protein with a targeted cytotoxicity for human skin cancer in vitro.

Published in:: Journal of Biomedical Science, 2012, v. 19, n. 1, p. 65, doi. 10.1186/1423-0127-19-65
Publication type:: Article

IMMUNE REACTIONS AGAINST THE RABBIT MYXOMA VIRUS.

Published in:

Trakia Journal of Sciences, 2016, v. 14, n. 2, p. 190, doi. 10.15547/tjs.2016.02.012

By:

Manev, I.;
Genova, K.

Publication type:

Article

Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease.

Published in:

Veterinary Record: Journal of the British Veterinary Association, 2012, v. 170, n. 12, p. 308, doi. 10.1136/vr.100366

By:

Spibey, N.;
McCabe, V. J.;
Greenwood, N. M.;
Jack, S. C.;
Sutton, D.;
van der Waart, L.

Publication type:

Article

A vaccine against myxomatosis and RHD: a step forward for rabbit health.

Published in:

2012

By:

Meredith, Anna

Publication type:

Editorial

Decrease in C-reactive protein levels in rabbits after vaccination with a live attenuated myxoma virus vaccine.

Published in:

Veterinární Medicína, 2016, v. 61, n. 10, p. 571, doi. 10.17221/159/2015-VETMED

By:

ONDRUSKA, L.;
PARKANYI, V.;
VASICEK, J.;
JURCIK, R.;
HANUSOVA, E.;
VASICEK, D.;
BALAZI, A.;
VIZZARRI, F.

Publication type:

Article

Oxidative stress in wild European rabbits naturally infected with myxoma virus and rabbit haemorrhagic disease virus.

Published in:

European Journal of Wildlife Research, 2018, v. 64, n. 4, p. 1, doi. 10.1007/s10344-018-1203-0

By:

Pacios-Palma, Isabel;
Moreno, Sacramento;
Selman, Colin;
Rouco, Carlos

Publication type:

Article

Works matching DE "MYXOMA virus"

Myxoma Virus Protein M029 Is a Dual Function Immunomodulator that Inhibits PKR and Also Conscripts RHA/DHX9 to Promote Expanded Host Tropism and Viral Replication.

Evolutionary History and Attenuation of Myxoma Virus on Two Continents.

The α2,3-Sialyltransferase Encoded by Myxoma Virus Is a Virulence Factor that Contributes to Immunosuppression.

Myxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity.

Myxoma Virus Oncolytic Efficiency Can Be Enhanced Through Chemical or Genetic Disruption of the Actin Cytoskeleton.

Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas <i>In Vitro</i> and <i>In Vivo</i>.

Resistance to Oncolytic Myxoma Virus Therapy in Nf1<sup>−/−</sup>/Trp53<sup>−/−</sup> Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon.

Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells.

SEROPREVALENCE AGAINST MYXOMA VIRUS IN LEPUS EUROPAEUS FROM BULGARIA.

Apoptosis-inducing effect of myxoma virus on human neuroglioma cell lines.

Recurrent Left Atrial Myxoma in a Young Patient: A Rare Entity.

Detection of rabbit Haemorrhagic disease virus 2 during the wild rabbit (Oryctolagus cuniculus) eradication from the Berlengas archipelago, Portugal.

Genetic characterization of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs.

Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor--resistant multiple myeloma.

Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma.

Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma.

Myxoma Virus dsRNA Binding Protein M029 Inhibits the Type I IFN-Induced Antiviral State in a Highly Species-Specific Fashion.

Myxoma Virus and the Leporipoxviruses: An Evolutionary Paradigm.

Molecular species identification, host preference and detection of myxoma virus in the Anopheles maculipennis complex (Diptera: Culicidae) in southern England, UK.

Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.

Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia.

Uncommon superficial angiomyxoma of the vulva complicated with condyloma acuminatum and Staphylococcus hominis infection: a mere example of gynecological immunocompromised district.

A bioactive peptide analogue for myxoma virus protein with a targeted cytotoxicity for human skin cancer in vitro.

IMMUNE REACTIONS AGAINST THE RABBIT MYXOMA VIRUS.

Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease.

A vaccine against myxomatosis and RHD: a step forward for rabbit health.

Decrease in C-reactive protein levels in rabbits after vaccination with a live attenuated myxoma virus vaccine.

Oxidative stress in wild European rabbits naturally infected with myxoma virus and rabbit haemorrhagic disease virus.